Skip to main content
. 2023 Jun 9;15:449–464. doi: 10.2147/NSS.S409883

Table 3.

Polysomnography (PSG) Parameters by Normal Spirometry, Restrictive or Obstructive/Mixed Impairments on Spirometry

Polysomnography Data Polysomnography Parameters Normal Spirometry (n=122) Restrictive Impairment (n=95) p-value Obstructive/Mixed Impairments (n=31) p-value
Sleep related variables Sleep latency 13 (4, 33) 18 (4.25, 33.5) 0.187 16.15 (4, 45) 0.436
REM latency 123 (72.5, 179.5) 124 (67, 230) 0.949 119 (75, 156.5) 0.866
Wake after sleep onset 53.6 (31.9, 100.75) 75.5 (39.9, 141) 0.085 77.1 (53, 157) 0.208
Sleep efficiency 84.15 (73.9, 89.3) 78.85 (67.4, 90) 0.026* 77.75 (62.1, 86.7) 0.093
Sleep efficiency <80% 48 (39%) 47 (52%) 0.063 18 (60%) 0.044*
Total sleep time 388 (344.5, 455) 396.5 (334.9, 480.9) 0.617 389 (330.5, 442.5) 0.874
Architecture N1 (%) 11.75 (7, 18.2) 11.3 (5.45, 21.3) 0.794 10.2 (5.6, 20) 0.572
N2 (%) 57.05 (50.3, 65.2) 61 (51.2, 76.9) 0.086 61.85 (53.8, 69.7) 0.143
N3 (%) 7.9 (2.3, 14.4) 5 (0, 11.7) 0.124 7.8 (2.4, 14.3) 0.971
REM (%) 18.85 (12.6, 23.7) 13.45 (7, 18.8) <0.001* 15.9 (9.8, 21.4) 0.203
Arousals Respiratory arousal index 11.8 (3.3, 25.3) 9.7 (3.4, 30.4) 0.579 14.6 (6.1, 18) 0.539
Spontaneous arousal index 3.35 (1.3, 6.3) 2.65 (1.1, 6) 0.300 3 (1.9, 5.2) 0.690
Total arousal index 22.75 (14.2, 37.3) 27.4 (13.3, 44.9) 0.142 24.7 (14.9, 31.4) 0.752
Apnoea-hypopnea index Total 21.45 (8.2, 45.8) 29.3 (12.8, 65) 0.176 31 (13.7, 50.3) 0.262
NREM 19.15 (6.25, 47.1) 27.4 (8.6, 62.6) 0.167 23.25 (16.1, 56.6) 0.602
REM 32.05 (8.5, 62.55) 52.2 (25.1, 73.2) 0.010* 55.1 (21.5, 74.5) 0.047*
Obstructive sleep apnoea No 105 (86%) 88 (93%) 0.651 28 (90%) 0.329
Mild 29 (28%) 23 (26%) 5 (18%)
Moderate 25 (24%) 19 (22%) 7 (25%)
Severe 51 (49%) 46 (52%) 16 (57%)
Oxygen saturation Total 94 (93, 96) 93 (91, 96) 0.136 92 (90, 94) 0.040*
Wake 95 (94, 96) 95 (92, 96) 0.999 94 (92, 95) 0.192
NREM 94 (93, 96) 93 (91, 96) 0.122 92 (89, 94) 0.033*
REM 94 (91, 96) 92 (87, 95) 0.038* 92.5 (87, 94) 0.146
Nadir 82 (75, 88) 77 (67, 84) 0.018* 78 (69, 85) 0.188
Continuous positive airway pressure (CPAP) Trialled CPAP 57 (54%) 60 (68%) 0.050* 16 (57%) 0.787
CPAP > 30 days 36 (63%) 36 (60%) 0.726 6 (38%) 0.073
Days used (%) 53.35 (12.2, 97.5) 20.55 (5.25, 86.35) 0.081 20.85 (7.8, 28.3) 0.430
Average hours used 5.53 (3.53, 7.15) 4.4 (3.17, 6.34) 0.213 3.17 (1.56, 5.32) 0.418
Days used >4 hours (%) 44.15 (10.55, 82.5) 12.5 (2.75, 55) 0.009* 8.3 (1.1, 22.8) 0.172
Adherent 14 (39%) 8 (22%) 0.129 1 (17%) 0.313

Notes: Data were median (interquartile range) or number (%). p-values obtained via univariate quantile regression for continuous outcomes and univariate logistic regression for binary outcomes, utilising “normal spirometry” as baseline reference. Fishers exact test was used for obstructive sleep apnoea presence and severity. *Indicates significance at p<0.05.

Abbreviations: N1/N2/N3, non-rapid eye movement stages 1, 2, 3; NREM, Non-Rapid eye movement; REM, Rapid eye movement.